Zodryl DEC 40 is a Oral Suspension in the Human Otc Drug category. It is labeled and distributed by Codadose, Inc.. The primary component is Pseudoephedrine Hydrochloride; Codeine Phosphate; Guaifenesin.
Product ID | 43378-123_b51a9a1b-ddbe-47fc-bd22-d9e078dccb9b |
NDC | 43378-123 |
Product Type | Human Otc Drug |
Proprietary Name | Zodryl DEC 40 |
Generic Name | Codeine Phosphate, Guaifenesin And Pseudoephedrine Hydrochloride |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2009-08-24 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | CodaDose, Inc. |
Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN |
Active Ingredient Strength | 15 mg/4.5mL; mg/4.5mL; mg/4.5mL |
DEA Schedule | CV |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-08-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-08-24 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
PSEUDOEPHEDRINE HYDROCHLORIDE | 14.998 mg/4.5mL |
SPL SET ID: | 7d1e58cc-5306-4c97-9f74-e364d0b023e5 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
43378-123 | Zodryl DEC 40 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-120 | Zodryl DEC 25 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-121 | Zodryl DEC 30 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-124 | Zodryl DEC 50 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-125 | Zodryl DEC 60 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-126 | Zodryl DEC 80 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |